Mattia Galli On Genomadix Cube Test: A Rapid Genetic Test to Predict The Response to Clopidogrel
Mattia Galli, Assistant Professor at Sapienza University of Rome, Associate Editor of European Heart Journal, reposted from Mater Dei General Hospital on LinkedIn:
”Would you take a life-saving drug knowing that in one case out of three this does not work? Probably not.
In the heart of Rome, one of the first centers in Italy to finally offer the possibility of predicting the response to the most widely used anti-caking drug, clopidogrel, with a simple and rapid genetic test.
The result of the test is integrated with the most up-to-date international recommendations on the subject, to which I had the honor of contributing, to offer a personalized assessment and improve the prognosis of patients in each specific clinical context.
After years of scientific research, it is time to turn science into real benefits for a more targeted and personalized care of cardiovascular patients.”
Mater Dei General Hospital shared on LinkedIn:
”What is the Genomadix Cube test?
It is a simple and non-invasive genetic test that helps to understand how our body responds to some fundamental drugs in cardiology, such as antiplatelet drugs that inhibit P2Y12 (clopidogrel, prasugrel or ticagrelor)
Let’s find out more with Dr. Mattia Galli
Info and reservations
Tel. 06 83 803”
Read the full article in JACC.
Article: International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 Update
Authors: Dominick J. Angiolillo, Mattia Galli, Dimitrios Alexopoulos, Daniel Aradi, Deepak L. Bhatt, Laurent Bonello, Davide Capodanno, Larisa H. Cavallari, Jean-Philippe Collet, Thomas Cuisset, Jose Luis Ferreiro, Francesco Franchi, Tobias Geisler, C. Michael Gibson, Diana A. Gorog, Paul A. Gurbel, Young-Hoon Jeong, Rossella Marcucci, Jolanta M. Siller-Matula, Roxana Mehran, Franz-Josef Neumann, Naveen L. Pereira, Konstantinos D. Rizas, Fabiana Rollini, Derek Y.F. So, Gregg W. Stone, Robert F. Storey, Udaya S. Tantry, Jurrien Ten Berg, Dietmar Trenk, Marco Valgimigli, Ron Waksman, Dirk Sibbing
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis